Susquehanna International Group’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-111,272
Closed -$4.33K 13278
2025
Q4
$4.33K Buy
111,272
+47,241
+74% +$2.2K ﹤0.01% 12100
2025
Q3
$2.41K Buy
+64,031
New +$2.77K ﹤0.01% 12164
2023
Q2
Sell
-20,491
Closed -$783 12187
2023
Q1
$783 Hold
20,491
﹤0.01% 12428
2022
Q4
$779 Hold
20,491
﹤0.01% 12189
2022
Q3
$1K Buy
+20,491
New +$1.85K ﹤0.01% 12986
2022
Q2
Sell
-13,880
Closed -$3K 13007
2022
Q1
$3K Sell
13,880
-34,973
-72% -$15.1K ﹤0.01% 12850
2021
Q4
$38K Buy
+48,853
New +$35.8K ﹤0.01% 12676

Other funds holding COCHW

Susquehanna International Group's COCHW Position: Q1 2026 in Review

Susquehanna International Group sold out of Envoy Medical Warrant (COCHW) in Q1 2026, closing a stake of 111,272 shares — an estimated $4.33K sold.

Susquehanna International Group first reported a position in COCHW in Q4 2021 and held it in 7 quarters. The position peaked at $38K in Q4 2021. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • Susquehanna International Group reported no remaining Envoy Medical Warrant position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 111,272 Envoy Medical Warrant shares in Q1 2026, an estimated $4.33K.
  • Susquehanna International Group first reported a position in Envoy Medical Warrant in Q4 2021 and held it in 7 quarters.
  • Susquehanna International Group's Envoy Medical Warrant position peaked at $38K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.